Chiron Investment Management LLC Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Chiron Investment Management LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 28.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,068 shares of the medical equipment provider's stock after selling 3,600 shares during the quarter. Intuitive Surgical accounts for about 1.6% of Chiron Investment Management LLC's portfolio, making the stock its 28th largest position. Chiron Investment Management LLC's holdings in Intuitive Surgical were worth $4,733,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Atala Financial Inc purchased a new position in Intuitive Surgical in the fourth quarter worth about $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Hurley Capital LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $28,000. Finally, Summit Securities Group LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at $30,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $1.40 during midday trading on Friday, hitting $482.74. 1,618,989 shares of the company traded hands, compared to its average volume of 1,599,026. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company's 50-day simple moving average is $522.23 and its 200-day simple moving average is $532.02. The company has a market cap of $171.94 billion, a PE ratio of 75.31, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Analyst Ratings Changes

Several research analysts have commented on the stock. Citigroup lifted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research note on Friday, January 24th. CICC Research assumed coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 price target for the company. UBS Group increased their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Raymond James upped their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, Robert W. Baird cut their price objective on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $611.81.

Insider Activity at Intuitive Surgical

In related news, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This trade represents a 63.13 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 over the last quarter. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.